Skip to ContentSkip to Navigation
How to find us drs. I.C. Kok


Studies to optimize selection for immunomodulatory cancer therapy with focus on immunoPET

Comparison of Carboplatin With 5-Fluorouracil vs. Cisplatin as Concomitant Chemoradiotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma

Zr-89-labeled Bispecific T-cell Engager AMG 211 PET Shows AMG 211 Accumulation in CD3-rich Tissues and Clear, Heterogeneous Tumor Uptake

As Standing Task Difficulty Increases, Corticospinal Excitability Increases in Proportion to COP velocity but M1 Excitability Changes are Participant-Specific: Corticospinal and M1 Excitability in Standing

Molecular Imaging in Cancer Drug Development

Zirconium-89 (89Zr)-labeled bispecific T-cell engager (BiTE (R)) AMG 211 PET imaging to determine AMG 211 biodistribution in patients with gastrointestinal (GI) adenocarcinomas

Zr-89-atezolizumab imaging as a non-invasive approach to assess clinical response to PD-L1 blockade in cancer

Comparison of carboplatin with 5-fluorouracil (carbo-5FU) versus cisplatin as concomitant chemoradiotherapy (CRT) for locally advanced head and neck squamous cell carcinoma (LA-HNSCC)'

Theranostics Using Antibodies and Antibody-Related Therapeutics

Meta-analysis and meta-regression of hypothalamic-pituitary-adrenal axis activity in functional somatic disorders

Read more